Demonstrated Safety and Tolerability Profile 1 With RADICAVA , the most common adverse reactions were contusion, gait disturbance, and headache 1, a (see footnote) Safety profile was demonstrated in pooled placebo-controlled trials b (see footnote) in which 184 patients with ALS were administered RADICAVA (edaravone) (60 mg) in 24-week treatment cycles
An earlier 12-week trial in 300 obese adults produced a genuine positive signal the 1 mg daily dosing arm showed a statistically significant 2.8 kg mean weight loss versus 0.8 kg in the placebo group and that result is what justified moving into the larger Phase IIb trial
Inflammatory back pain from AS does the opposite
These symptoms aren't always due to vitamin B12-deficiency anaemia, but if you have them see your GP. Avoiding vitamin B12 deficiency Experts say adults aged 19 to 64 require around 1.5 micrograms a day of vitamin B12, and you should be able to get this through your diet
Putting the brain on the map: use of transcranial magnetic stimulation to assess and induce cortical plasticity of upper-extremity movement